Immune Response to SARS-CoV-2 Third Vaccine in Patients With Rheumatoid Arthritis Who Had No Seroconversion After Primary 2-Dose Regimen With Inactivated or Vector-Based Vaccines

CONCLUSION: In this RA cohort, 91% of patients who failed to seroconvert after 2 doses of SARS-CoV-2 vaccine presented detectable anti-SARS-CoV-2 IgG after a third dose. The use of ABA was associated with a lower frequency of specific T cell response.PMID:36182107 | DOI:10.3899/jrheum.220469

Source: Journal of Rheumatology - October 1, 2022 Category: Rheumatology Authors: Carolina A Isnardi Osvaldo L Cerda Margarita Landi Leonel Cruces Emilce E Schneeberger Claudia Calle Montoro Mar ía Agustina Alfaro Brian M Rold án Andrea B G ómez Vara Pamela Giorgis Roberto Alejandro Ezquer Mar ía G Crespo Rocha Camila R Reyes G óm Source Type: research